Novel multitarget analgesic candidate SZV-1287 demonstrates potential disease-modifying effects in the monoiodoacetate-induced osteoarthritis mouse model

IntroductionMonoiodoacetate (MIA)-induced osteoarthritis (OA) is the most commonly used rodent model for testing anti-OA drug candidates. Herein, we investigated the effects of our patented multitarget drug candidate SZV-1287 (3-(4,5-diphenyl-1,3-oxazol-2-yl) propanal oxime) that is currently under...

Disgrifiad llawn

Manylion Llyfryddiaeth

Prif Awduron:	Ádám István Horváth, Kata Bölcskei, Nikolett Szentes, Éva Borbély, Valéria Tékus, Bálint Botz, Kitti Rusznák, Anett Futácsi, Boldizsár Czéh, Péter Mátyus, Zsuzsanna Helyes
Fformat:	Artigo
Iaith:	Inglês
Cyhoeddwyd:	Frontiers Media S.A. 2024-09-01
Cyfres:	Frontiers in Pharmacology
Pynciau:	osteoarthritic pain analgesic drug development semicarbazide-sensitive amine oxidase amine oxidase copper containing 3 vascular adhesion protein 1 transient receptor potential vanilloid 1
Mynediad Ar-lein:	https://www.frontiersin.org/articles/10.3389/fphar.2024.1377081/full
Tagiau:	Ychwanegu Tag Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!